组织殖民扩散的瘤细胞分泌前列腺素E2以促进NK细胞功能障碍并逃避抗转移性免疫力
Anna-Marie Pedde1, Hyunu Kim2, Sainitin Donakonda1
1Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Cell reports
|November 14, 2024
概括
散布的瘤细胞分泌前列腺素E2 (PGE2) 损害自然杀手 (NK) 细胞的抗转移免疫力. 针对PGE2-EP2/EP4通路恢复NK细胞功能,控制转移性疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 转移研究 转移研究
背景情况:
- 自然杀手 (NK) 细胞对于消除循环中的瘤细胞和预防转移至关重要.
- 散布的瘤细胞 (DTC) 可以逃避在转移部位的免疫监测.
- 了解瘤细胞逃避机制对于开发有效的癌症疗法至关重要.
研究的目的:
- 研究扩散瘤细胞 (DTC) 如何诱导肺中的NK细胞功能障碍.
- 阐明瘤细胞抑制NK细胞抗转移活动的分子机制.
- 探索针对已识别的抑制途径的治疗潜力.
主要方法:
- 使用小鼠模型的肺转移.
- 通过DTCs分析了前列腺素E2 (PGE2) 的分泌.
- 研究NK细胞功能,基因表达和细胞因子的产生.
- 研究了PGE2受体EP2和EP4在NK细胞功能障碍中的作用.
- 与人类癌症患者数据相关联的发现.
主要成果:
- 在小鼠肺中的DTC分泌PGE2,导致局部NK细胞功能障碍.
- 通过EP2和EP4受体发送PGE2信号,重新编程NK细胞基因表达,从而损害抗转移性细胞因子的产生.
- PGE2-EP2/EP4轴与人类转移性瘤中的NK细胞功能障碍有关.
- 阻断NK细胞中的EP2/EP4信号恢复了它们的功能并控制了转移性生长.
结论:
- 转移性瘤细胞利用PGE2-EP2/EP4信号轴抑制NK细胞的抗转移性免疫力.
- 这一途径是克服转移性癌症免疫逃避的有希望的治疗标.
- 恢复NK细胞功能是控制转移性疾病的可行策略.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
148
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
148
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849


